Login

Viorel Panait on the Evolution of Romanian-Ukrainian Collaboration and the Perspectives of Constanta Port | Panait Viorel - CEO of Comvex 00:10:00

Share On Facebook Share On Twitter

Panait Viorel is the CEO of Comvex Constanta.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Leadership in Transformative Capital: Michael Fisch and American Securities| Michael Fisch, CEO, American Securities.
00:10:00
Incapital and 280 CapMarkets merged to form InspereX, a distinctive fintech company.
00:10:00
Insights on the Future of Workspaces and Real Estate: A Conversation with Michael Emory|CEO, Allied Properties Real Estate Investment Trust (REIT)
00:10:00
Lawrence Stroll Discusses Aston Martin's F1 Reveal and Pandemic Impact on Business | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.
00:10:00
Top Absolute Return Performers: Fatima Khizou’s Picks for Consistent Gains Across Market Cycles | Fatima Khizou - Fund Analyst, Morningstar
00:10:00
Mineral Commodities Ltd. - Expanding Horizons in Mineral Sands
00:10:00
Jeffrey Gundlach's Market Analysis: Navigating Recession Predictions and Portfolio Strategies | Jeffrey Gundlach, CEO , DoubleLine Capital.
00:10:00
EGM Milan Meeting: Connecting Investors with Leading Companies like Comal SPA | Alfredo Balletti, CEO, Indo National Ltd.
00:10:00
In a discussion with Nick Bolton, CEO of Oxford Metrics Plc, hosted by Oli Barrett MBE, marking the third consecutive year of the event.
00:10:00
Kuniko Limited: Driving Electromobility with European-Focused Mineral Exploration | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Safeguarding HIPAA & PHI: Expert Insights and Case Studies
00:10:00
The Firm is backed by a well-diversified pool of investors, endowments, foundations, and executives from the world’s top technology|Will Price,Founder & General Partner,Next Frontier Capital

© 2026 Nehu